GRAIL Completes Final Study Visits for the NHS-Galleri Trial; Final Results Expected in 2026 PATHFINDER 2 is a prospective, multi-center, interventional study evaluating the safety and performance of ...
NASA’s twin GRAIL spacecraft were delivered by its builder Lockheed Martin (NYSE: LMT) to Kennedy Space Center, Fla., on May 20. The two vehicles will undergo four months of final testing and ...
The goals of the program are to: a) enhance the scientific return from the GRAIL mission by broadening participation in the mission, and b) augment the existing GRAIL science team to include new ...
GRAIL Completes Enrollment of More Than 35,000 Participants in the PATHFINDER 2 Study; Results From the First 25,000 Participants Expected in the Second Half of 2025 GRAIL Completes Final Study Visits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results